QQ, M., AP, W., HC, H., Y, J., YY, W., HJ, M., . . . KX, S. (2018). Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease. Dove Medical Press.
Chicago Style (17th ed.) CitationQQ, Meng, Wang AP, Hua HC, Jiang Y, Wang YY, Mu HJ, Wu ZM, and Sun KX. Intranasal Delivery of Huperzine A to the Brain Using Lactoferrin-conjugated N-trimethylated Chitosan Surface-modified PLGA Nanoparticles for Treatment of Alzheimer’s Disease. Dove Medical Press, 2018.
MLA (8th ed.) CitationQQ, Meng, et al. Intranasal Delivery of Huperzine A to the Brain Using Lactoferrin-conjugated N-trimethylated Chitosan Surface-modified PLGA Nanoparticles for Treatment of Alzheimer’s Disease. Dove Medical Press, 2018.